PROCEDURES

Surgical Procedures

Dr. Salz Lasik Vision Refractive surgery procedures include the following:

* "All-Laser" LASIK Surgery
* Laser in-situ keratomileusis (LASIK)
* Conductive Keratoplasty (CK)
* Photorefractive keratectomy (PRK)
* Clear lens extraction (CLE)
* Phakic intraocular lenses (PIOL)

o (STAAR Surgical-FDA Approved)
o Alcon Anterior Chamber Lens –Currently under FDA Studies

"All-Laser" LASIK Surgery Intralase Pulsion™ FS Laser system. The Intralase system creates a corneal flap of a precise thickness and diameter with a lower suction level than a standard microkeratome without using a blade. this makes creating a flap safer than standard microkeratomes using higher suction and blades.

Intralase presents proprietary femtosecond laser technology that will enable patients to choose vision correction surgery with confidence. The Intralase Pulsion™ FS Laser offers refractive surgeons and incomparable safety platform, optimal precision and total control as the only All-Laser alternative to the mechanical microkeratome.

LASER IN-SITU KERATOMILEUSIS (LASIK) LADARVision® CustomCornea® system or the VISX Laser system. Involves cutting a large superficial flap (using a microkeratome) from the cornea (diameter of 8.5 to 9 mm for a thickness of 130 to 180 µm); the cut starts from the temporal side and stops nasally before a complete circle has been cut (producing a nasal hinge of 1 to 1.5 mm). The flap is raised, and an ablation is performed in situ with the excimer laser centered on the prepupillary area. The flap is then replaced without sutures. The entire procedure is performed under topical anesthesia as an outpatient procedure.

LADARVision Custom Laser Vision Correction System, incorporating state-of-the-art technology, is distinctly different from other vision correction systems available today. It uses the patented LADARTracker™ eye tracking system. This active eye tracking technology helps your doctor optimize the vision procedure for you. Find out how LADARVision® takes the worry out of vision correction and why it may be right for you. The LADARVision is FDA approved to correct myopia, hyperopia and astigmatism. Dr. Salz was principal investigator for 3 different FDA studies for this laser.

VISX invented the technology for vision correction more than 15 years ago. The VISX laser has FDA approval to treat myopia, hyperopia, and astigmatism. Dr. Salz was principal Investigator for 4 different FDA studies for VISX approval.

LASIK Advantages:

* •Minimal post-operative discomfort
* •Rapid visual recovery-usually next day
* •Superior results in moderate & high myopia, astigmatism, and hyperopia
* •Reduced risk of corneal haze in higher corrections
* •Re-operations (enhancements) easier


Bilateral Simultaneous LASIK?


NearVision CK (Conductive Keratoplasty) can change how the eye focuses light by reshaping the cornea to improve near vision. It uses a controlled release of radiofrequency (RF) energy to shrink corneal tissue, which steepens the cornea. This steepening creates a safe and predictable modification to the topographical (surface) curvature of the cornea for the temporary reduction of presbyopic and hyperopic symptoms. CK(R) is usually performed on only one eye and is designed to reduce the dependence on reading glasses.


PHOTOREFRACTIVE KERATECTOMY (PRK) involves sculpting the surface of the cornea to a new curvature with a special cold laser (excimer) by vaporizing the surface layer through a series of precise laser pulses under computer control. PRK in the United States has been approved by the FDA for the correction of myopia and hyperopia. Dr. Salz has performed PRK on thousands of eyes since 1990.


CLEAR LENS EXTRACTION (CLE) involves the removal of the internal lens of the eye, as in a cataract operation. A lens implant of a stronger power, as calculated by special measurements and formulas, is then placed inside the eye.


PHAKIC INTRAOCULAR LENS (PIOL) involves placement of a lens implant inside the eye for the correction of either nearsightedness or farsightedness. This lens becomes in effect an internal contact lens inside the eye rather than on the surface of the eye. The lens manufactured by STAAR Surgical received final FDA approval in 2006.

Currently under FDA Clinical Trial is the Alcon Anterior Chamber Phakic Implant for myopia.